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Thematernal and paternal copies of the genome are both required formammalian development, and this is primarily due to
imprinted genes, those that are monoallelically expressed based on parent-of-origin. Typically, this pattern of expression is
regulated by differentially methylated regions (DMRs) that are established in the germline andmaintained after fertilization.
There are a large number of germline DMRs that have not yet been associated with imprinting, and their function in de-
velopment is unknown. In this study, we developed a genome-wide approach to identify novel imprinted DMRs in the hu-
man placenta and investigated the dynamics of these imprinted DMRs during development in somatic and extraembryonic
tissues. DNAmethylation was evaluated using the Illumina HumanMethylation450 array in 134 human tissue samples, pub-
licly available reduced representation bisulfite sequencing in the human embryo and germ cells, and targeted bisulfite
sequencing in term placentas. Forty-three known and 101 novel imprinted DMRs were identified in the human placenta
by comparing methylation between diandric and digynic triploid conceptions in addition to female and male gametes.
Seventy-two novel DMRs showed a pattern consistent with placental-specific imprinting, and this monoallelic methylation
was entirely maternal in origin. Strikingly, these DMRs exhibited polymorphic imprinted methylation between placental
samples. These data suggest that imprinting in human development is far more extensive and dynamic than previously re-
ported and that the placenta preferentially maintains maternal germline-derived DNA methylation.
[Supplemental material is available for this article.]
The two haploid copies of the genome are not interchangeable,
as both a maternally and paternally inherited copy is required
for mammalian development. This is primarily due to imprinted
genes, those that are expressed from a single allele based on par-
ent-of-origin. This class of genes is particularly important for fetal
and placental development (Frost and Moore 2010).
The monoallelic expression of imprinted genes is controlled
by differentially methylated regions (DMRs) that are established
either as “primary” (germline) imprints in the female ormale gam-
etes or as “secondary” (somatic) imprints in embryonic develop-
ment. Imprinted genes can occur in isolation but are often
found in centrally regulated clusters. Imprinted DMRs are all
CpG-rich regions; however, paternal DMRs tend to be intergenic
while maternal DMRs are located at promoters or intragenic re-
gions (Kobayashi et al. 2006; Schulz et al. 2010).
Primary imprinted DMRs are erased and reestablished during
germline development of each generation dependent on the sex of
the embryo (Kelsey and Feil 2013). Shortly after germ cell specifica-
tion in the embryo, there is a genome-wide removal of DNAmeth-
ylation, thereby erasing all prior parentally inherited imprints
(Seisenberger et al. 2012). Methylation is then reacquired in sper-
matocytes around the time of birth in males, while in females,
DNA methylation is not fully established until oocyte growth in
adulthood (Lucifero et al. 2004; Henckel et al. 2012). Once estab-
lished, imprints are then passed on to offspring upon formation
of the zygote and are maintained through the dynamic epigenetic
reprogramming in the early embryo. Our current knowledge about
themechanisms and dynamics of imprinting has been determined
almost exclusively using mouse models; however, evidence from
human studies suggests that these processes are largely conserved
(Ishida and Moore 2013; Guo et al. 2014).
Currently, 151 imprinted genes have been identified in
mouse (www.mousebook.org), while there appears to be less ex-
tensive imprinting in humans, with only 78 genes identified
(http://igc.otago.ac.nz). Despite this difference, the majority of
the well-studied imprinted clusters are conserved in their ex-
pression, methylation patterns, and synteny (Onyango et al.
2000). In both mice and humans, a large number of DMRs of un-
known function have been reported between sperm and oocyte
(Smallwood et al. 2011; Guo et al. 2014), which raises the question
as to whether imprinting is more extensive in the genome than
previously reported.
Over the past decade, multiple approaches to identify novel
imprinted genes in the human genome have been utilized, includ-
ing comparative methodologies for genomic features (Luedi et al.
2007), gene expression (Metsalu et al. 2014; Babak et al. 2015),
and DNA methylation (Choufani et al. 2011; Yuen et al. 2011a;
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Das et al. 2013; Stelzer et al. 2013; Court
et al. 2014; Docherty et al. 2014) in vari-
ous tissues. Importantly, these studies
have resulted in the discovery and vali-
dation of many imprinted genes; howev-
er, the candidate lists are often not
replicated between studies. Until recent-
ly, the genome-wide pattern of DNA
methylation in human oocytes was not
known (Guo et al. 2014), preventing
the definitive identification of novel pri-
mary imprints in humans. In this study,
we describe the dynamics of known im-
printed DMRs throughout human devel-
opment in somatic and extraembryonic
tissues and identify novel germline im-
printed DMRs utilizing gametic DNA
methylation in combination with a
validated approach of comparing placen-
tal samples with genomic imbalances
(Yuen et al. 2011a).
Results
Characterization of known imprinted
DMRs in human development
To evaluate imprinting in the human
placenta, we identified DMRs (≥3 CpGs
within 500 bp) between five diandric
(two paternal copies of the genome and
one maternal) and five digynic (two ma-
ternal copies and one paternal) triploid
placentas, measured by the Illumina
HumanMethylation450 BeadChip array
(450K array) (Fig. 1A). Eight hundred
eighty-two candidate DMRs, encompass-
ing 6807 probes (CpG sites), were identi-
fied (Supplemental Table 1), including
43 that overlapped previously reported
human imprinted DMRs (Supplemental
Table 2; Court et al. 2014).
DNA methylation at these 43
known DMRs was assessed using the
450K array in fetal and extraembryonic
tissues and using publicly available re-
duced representation bisulfite sequenc-
ing (RRBS) in human gametes and
embryos (Guo et al. 2014). Thirty-seven
DMRs were informative for germline
DNA methylation and, as expected, the
majority showed >50% difference in
DNA methylation between germ cells,
including two paternal and 32 maternal
germline DMRs (Fig. 1B). The remaining
three DMRs (MEG3, ZNF597, and GNAS
DMR1) were unmethylated both in
germ cells and the early embryo, suggest-
ing these are somatic DMRs (Fig. 1B).
Among the known DMRs, 15 are placen-
tal-specific in humans (Court et al. 2014)
and all showed differential methylation
Figure 1. Characterization of known imprintedDMRs in humandevelopment. (A) Digynic triploid con-
ceptions contain two maternal (white) and one paternal (gray) genome, while diandric triploid concep-
tions contain one maternal and two paternal genomes. By comparing digynic (N = 5) and diandric (N =
5) triploid placental villi, DMRswere identified, defined as≥3CpGswithin 500 bp. An example plot shows
amaternal DMR near PEG3, which ismore highlymethylated among digynic triploid samples (black line),
compared to diandric triploid samples (red line) across 37 CpG sites over a ∼4-kb region. (B) DNA meth-
ylation through early humandevelopment is shown for 43DMRs, identified between triploid samples that
overlap previously reported imprinted DMRs (Court et al. 2014). DNAmethylation for human germ cells,
early embryonic stages (zygote, two-cell, four-cell, eight-cell, andmorula stage embryos), inner cell mass,
and trophectoderm is an average of CpG sites across each DMRmeasured by RRBS. DNAmethylation for
placental villi, fetal tissues (brain, kidney, muscle, and spinal cord), and whole blood was an average of
450K array probes across each DMR. Primary (germline) imprinted DMRs (light gray), placental-specific
DMRs (black), and secondary DMRs (dark gray) are denoted. Parental origin of DNAmethylation is desig-
nated asmaternal (magenta) or paternal (blue).White boxes in the heatmap indicateDMRswith no data.
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between oocytes and sperm, with a mean difference of 67.5% (Fig.
1B). These placental-specific DMRs are intermediately methylated
in both the inner cell mass (ICM) (35.6%) and trophectoderm (TE)
(34.1%) of the blastocyst, suggesting that they are transiently im-
printed in embryo, not just extraembryonic TE (Fig. 1B).
Identification of novel imprinted placental DMRs
We sought to identify novel imprinted DMRs by identifying CpG
islands (CGIs) that showed a profile consistent with imprinting in
early human development: DMRs that were both differentially
methylated in the germline and between triploid placental sam-
ples. First, CGIs that were differentiallymethylated in the germline
and intermediately methylated in blastocysts were identified
(specific criteria detailed in the Methods), which included 1222
oocyte-specific and 288 sperm-specific DMRs (Fig. 2A). Of these
candidate CGIs, 101 novel regions overlapped with the 882
DMRs identified in triploid placental villous samples (Fig. 2B).
All 101 novel DMRs derived methylation from the oocyte, and
the majority (N = 72) showed a placental-specific pattern of im-
printing (Fig. 2C).
To confirm that the novel DMRs maintain imprinted allele-
specific methylation throughout development, allelic methyla-
tion was evaluated in oocytes, sperm, ICM, and TE for known
and novel DMRs. This reaffirmed that ∼50% of DNA strands in
the ICM and TE were partially/fully methylated and the propor-
tion of methylated alleles was not significantly different between
known and novel DMRs (Fig. 3A). It can be inferred that these
methylated alleles were almost entirely derived from the oocyte
(Fig. 3A), because it is assumed that there is almost no de novo
methylation in the preimplantation embryo (Seisenberger et al.
2013).
In placenta, allelic DNA methylation was assayed at known
and novel DMRs using multiplexed bisulfite sequencing
Figure 2. Identification of novel imprinted placental DMRs. (A) DNAmethylation is shown for oocyte-specific (left panel) and sperm-specific (right panel)
DMRs in human gametes and early embryonic stages (zygote, two-cell, four-cell, eight-cell, and morula stage embryos), ICM, and TE. DMRs were defined
as CGIs that showed a >50%methylation difference between gametes, with intermediate methylation (15%–60%) in the ICM and TE. (B) The number of
DMRs that overlap between those identified between human gametes and those identified between triploid placental samples is shown. (C) DNA meth-
ylation through early human development is shown for the 101 novel imprinted DMRs. DNA methylation for human gametes, early embryonic stages
(zygote, two-cell, four-cell, eight-cell, andmorula stage embryos), ICM, and TE is an average of CpG sites across each DMR,measured by RRBS. DNAmeth-
ylation for placental villi, fetal tissues (brain, kidney, muscle, and spinal cord), and whole blood was an average of 450K array probes across each DMR.
Seventy-two novel DMRs showed a placental-specific pattern of imprinting, defined as <25% or >75% methylation in somatic tissues and intermediately
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Figure 3. Imprinted methylation of novel placental DMRs. (A) DNA methylation was averaged across reads with ≥5 CpGs from RRBS. The proportion
of reads that was completely unmethylated (black), methylated (red), or had mixed methylation (gray) is shown for oocyte, sperm, ICM, and TE for germ-
line known (N = 40) and novel (N = 101) DMRs. The proportion of methylated alleles did not differ between known and novel DMRs (P = 0.981, χ2 test). (B)
DNAmethylation was averaged across reads with≥5 CpGs frommultiplexed bisulfite sequencing in 16 placental villi and 12matched trophoblast samples.
Distribution of read methylation across DMRs (binned in 10% intervals) is shown in the density plot, with a density heat map in grayscale showing the
distribution at each known (orange) and novel (blue) DMR below. DMRs with a minimum read depth of ≥5 were reported. (C) Average DNA methylation
is shown for the methylated and unmethylated allele at known (orange) and novel (blue) DMRs containing a heterozygous SNP. Each row corresponds to
one heterozygous SNP for one individual at one DMR; for loci with more than one informative SNP, the SNP number is designated after the sample name.
Parental origin was assigned where informative, with maternal (red) and paternal (blue) monoallelic methylation, alleles with no differential methylation
(gray), and uninformative alleles (white) denoted.
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(Supplemental Table 5) in 16 term placental villi samples
with matched isolated trophoblast (N = 12) and parental blood
(N = 20). One hundred two DMRs (32 known and 70 novel) were
successfully assayed, revealing a bimodal distribution of read
methylation in term placenta and trophoblast at these loci (Fig.
3B), consistent with that in the ICM and TE (Supplemental Fig.
1). This bimodal methylation pattern is indicative of monoallelic
methylation, as opposed to heterogeneous CpG methylation ex-
pected at nonimprinted, intermediately methylated loci. DMRs
that contained heterozygous SNPs showed that indeed this bimo-
dal methylation pattern was attributable to monoallelic methyla-
tion (Fig. 3C). Furthermore, DMRs with informative parental
origin showed that monoallelic methylation was entirely mater-
nally derived, with the exception of paternally methylated H19
(Fig. 3C).
Polymorphic imprinted methylation in the human placenta
Strikingly, methylation across the novel DMRs was highly poly-
morphic, with 50% of heterozygous samples demonstrating
monoallelic methylation and the remaining showing a complete
loss of imprinting at these loci (Fig. 3C). The frequency of poly-
morphic imprinting was similar in placental villi (50.0%) and tro-
phoblast (49.4%) (Supplemental Table 3), and allelic methylation
was highly correlated between matched trophoblast and whole
villi from the same individual (N = 34, R2 = 0.73, P < 0.0001,
Spearman rank correlation). This suggests that the pattern of poly-
morphic imprinting is not attributable to differences in cell com-
position. Polymorphic methylation was confirmed among the
63 placental samples run on the 450K array (Fig. 4A), which in-
cluded four samples assayed by multiplexed bisulfite sequencing.
Using hierarchical clustering, the samples did not cluster by gesta-
tional age, suggesting polymorphicmethylation across these loci is
also not gestational age-dependent. Furthermore, polymorphic
imprinting at these DMRswas placental-specific, as somatic tissues
showed significantly less variability than placenta (P < 2.2 × 10−16)
(Fig. 4B). These data suggest that polymorphic imprinting is perva-
sive in the human placenta.
The placental-specific imprinted genes reported to date in hu-
man and mouse are not well-conserved (Frost and Moore 2010);
therefore, we evaluated the DNA methylation of orthologous re-
gions to placental-specific DMRs in mouse development using
publicly available data (Smith et al. 2012, 2014; Hon et al. 2013).
Only six DMRs showed differential germline DNA methylation
in mouse gametes, but only one locus, orthologous to NAV2,
showed a pattern consistent with placental-specific imprinting
(Supplemental Fig. 2).
Timing of loss of imprinting in human embryonic lineages
To assess the developmental timing of loss of imprinting at
placental-specific imprinted DMRs in somatic lineages, we
Figure 4. Polymorphic imprinted methylation in the human placenta. (A) DNA methylation shows a polymorphic pattern across known (orange) and
novel (blue) DMRs among 63 placental samples from 1st (N = 5, black), 2nd (N = 9, light gray), and 3rd (N = 49, dark gray) trimester samples. The color
scale was set to show those samples that deviate from the intermediate range of methylation. (B) Mean standard deviation across all DMRs (N = 144) is
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took advantage of the methylation patterns observed in isolated
extraembryonic cell types. The various cells contributing to
the human placenta vary in the timing of differentiation and
also the degree to which they comprise cells from embryonic ori-
gins. As extraembryonic tissues progressively originate later
in development, they are more similar to the embryo (Fig. 5A).
We found that the trophoblast and mesenchymal core of the
placental villi showed the expected intermediate methylation
at known placental-specific DMRs (51.3% and 46.5%, respec-
tively). This supports that these DMRs are still imprinted in
the TE and ICM after the blastocyst stage; while trophoblast
originates entirely from the TE, mesenchyme is a mix of cell
types largely derived from the ICM-derived extraembryonic
mesoderm (Fig. 5A). Contrastingly, the average methylation
was lower in chorion (33.0%) and amnion (8.3%) (Fig. 5B), and
both mostly originate later from the extraembryonic mesoderm
(Fig. 5A).
The exact developmental timing and origin of amnion and
chorion are not firmly established. In mouse and, likely, in hu-
man, chorion is derived from both the TE and extraembryonic
mesoderm (Downs 2011; Pereira et al. 2011), while molecular
data in human suggest that there may also be a later contri-
bution from epiblast, prior to primitive streak formation at
day 15, to both chorion and amnion (Robinson et al. 2002;
Penaherrera et al. 2012). The relative loss of DNA methylation
observed in chorion and amnion compared to placental villi sug-
gests that imprinting at placental-specific DMRs in the embryon-
ic lineages has already begun to be lost at the time of primitive
streak formation (Fig. 5B). Thus, it appears that these loci are
either passively or actively losing methylation from the maternal
allele, while much of the genome is acquiring de novo DNA
methylation concomitant with somatic differentiation (Smith
et al. 2012).
Characteristics and function of placental-specific DMRs
The monoallelic methylation of placental-specific DMRs (16
known and 72 novel) may be attributable to targeted protection
of these regions or to the fact that these regions are a vestige of em-
bryonic methylation patterns. To evaluate this, we first assessed
whether there was evidence of de novo methylation in the post-
implantation placenta. One thousand three hundred fifty-two
CGIs were fully methylated in both oocyte and sperm, and are
therefore not imprinted, and retained intermediate DNAmethyla-
tion in the ICM and TE. In somatic tissues, almost all of these CGIs
undergo de novo methylation to become fully methylated
(83.2%), and this was similarly observed in the placenta (70.1%)
(Supplemental Fig. 3A), suggesting the placenta exhibits a phase
of post-implantation de novo DNA methylation. In addition, the
majority of placental-specific DMRs (80.7%) were not associated
with previously described large partially methylated domains
characteristic of the placenta (Supplemental Fig. 3B; Schroeder
et al. 2013). Together, these findings suggest that placental-specif-
ic DMRs may be specifically protected from loss or gain of
methylation.
Zinc finger protein 57 (ZFP57) and di-/tri-methylation of
histone 3 lysine 9 (H3K9me2/3) have been shown to protect im-
printed DMRs from demethylation during embryonic reprogram-
ming in mouse (Li et al. 2008; Nakamura et al. 2012) and thus
may be important to facilitate the protection of placental-specific
imprinting in humans. We observed a slightly higher proportion
of placental-specific DMRs (62.9%) with at least one ZFP57 con-
sensus sequence (TGCCGC) (Quenneville et al. 2011) than CGIs
genome-wide (51.5%; P = 0.04), which was comparable to known
imprinted DMRs (70.8%; P = 0.63) (Fig. 6A). Placental-specific
DMRs were also enriched for H3K9me3 in placenta compared to
somatic tissues (muscle, P = 2.2 × 10−16 and amnion, P = 2.2 ×
10−16) (Fig. 6B; Supplemental Fig. 4). However, this enrichment
was not a unique feature, as all CGIs were enriched for H3K9me3
in placenta compared to somatic tissue (muscle, P = 2.2 × 10−16
and amnion, P = 3.1 × 10−14) (Fig. 6B; Supplemental Fig. 4). These
findings suggest that ZFP57 and H3K9me3 may, at least partially,
be important for the maintenance of monoallelic DNA methyla-
tion at placental-specific DMRs; however, this is likely not a specif-
ic mechanism.
To investigate the potential role for placental-specific im-
printing, gene expression in placenta was assessed using publicly
available RNA-seq data sets (Bernstein et al. 2010; Yan et al.
2013; Metsalu et al. 2014). Fifty percent of the placental-specific
DMRs had an associated gene that was expressed in at least one
developmental stage (RPKM> 0.1) (Fig. 6C; Supplemental Table
6). However, gene ontology analysis revealed no enrichment for
pathways typically associated with imprinted genes, such as fetal
growth or placentation. The top gene ontology terms included al-
ternative splicing, expression in the brain, splice variants, and the
extracellular region (Supplemental Table 7).
Figure 5. Timing of loss of imprinting in human embryonic lineages. (A)
Schematic representation of the developmental origins of the extraembry-
onic cell types is shown,with TE-derived cells (dark blue), ICM-derived cells
(green), and cells with mixed origin (turquoise) denoted. (B) The distribu-
tion of DNAmethylation for known placental-specific DMRs that lose DNA
methylation in somatic tissues (N = 14) is shown for extraembryonic cell
types isolated from term placenta.Methylation for trophoblast andmesen-
chyme is an average from 1st, 2nd, and 3rd trimester samples. TE-derived
cells (dark blue), ICM-derived cells (green), and cells with mixed origin
(turquoise) are denoted. Extraembryonic cell types are ordered based on
the approximate timing in development when each cell type is derived.
The window of epigenetic reprogramming highlights the period in which
DNA methylation at placental-specific DMRs is likely being erased in the
ICM-derived lineage.
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Discussion
In this study, DNA methylation in human gametes and triploid
placental villi was used to identify germline imprinted DMRs.
We found 43 imprinted DMRs in placenta that overlapped with
previously reported imprinted DMRs initially identified in somatic
tissues (Court et al. 2014), and 34 of these were confirmed to be
germline imprints. Fifteen DMRs reported by Court et al were
not identified in this study; notably, 10 of these did not show
germline differential methylation and thereforemay be secondary
DMRs that are not fully established in placenta. Fifteen knownpla-
cental-specific DMRs did show differential germline methylation.
This is supported by a similar finding in an independent study of
oocyte DNA methylation (Okae et al. 2014); however, these find-
ings contradict a previous report suggesting that these regions
are unmethylated in human gametes (Court et al. 2014). This dis-
crepancy may be explained by the use of parthenogenetic embry-
onic stem cells as a proxy for the oocyte methylome in that study
(Court et al. 2014).
Recently, it was shown that many regions of the genome
are differentially methylated between oocyte and sperm beyond
the widely studied imprinted DMRs (Smallwood et al. 2011;
Kobayashi et al. 2012; Guo et al. 2014), and the importance of
this DNA methylation during development has been unclear to
date. We have determined that some of the additional differential
methylation in the human germline results in more widespread
imprinting, specifically in the placenta. We identified 101 novel
maternal germline imprintedDMRs in human placenta and found
that 72 were placenta-specific. The monoallelic DNA methylation
at these DMRs was validated by targeted multiplexed bisulfite se-
quencing in placenta and trophoblast, confirming maternally de-
rived methylation in all informative cases.
While the importance of imprinting in placental develop-
ment has been well-established (Varmuza and Miri 2015), the
role of placental-specific imprinting has not been fully explored.
Consistent with previously reported placental-specific imprinted
genes (Frost and Moore 2010), the human placental-specific
DMRs we identified were not conserved in mouse. This is some-
what unsurprising, because although imprinting is quite robustly
conserved across eutherian mammals (Renfree et al. 2013), many
of the additional germline DMRs identified thus far have not
been conserved in methylation state across species (Smith et al.
2014). There has not been a genome-wide investigation of placen-
tal-specific imprinting in many other species, and therefore the
extent and role of placental-specific imprinting in eutherianmam-
mals is unclear.
All 101 novel DMRs we identified had maternally inherited
DNA methylation, raising the number of maternal germline im-
printed DMRs to at least 140 loci in placenta.With only two pater-
nally derived germline imprinted DMRs identified, it suggests that
the maternal genome is almost solely responsible for inter-genera-
tional epigenetic inheritance, in the form of germline imprinted
DMRs. In the assessment of methylation at all CGIs in germ cells
and embryos, we observed that oocyte-derived DNA methylation
is more likely to be retained in the blastocyst; this is consistent
with the majority of imprinted domains being maternal in origin
and with previous observations made in the mouse (Smallwood
et al. 2011). The maternally inherited DNA in the embryo is pri-
marily passively demethylated after fertilization, as opposed to
the active demethylation that occurs on paternal DNA (Santos
et al. 2002; Inoue and Zhang 2011); this passive demethylation
may more readily allow oocyte-derived methylation to be main-
tained. In addition, maternal DMRs are CG-rich (Kobayashi et al.
2006) and may therefore be more likely to contain a CG-rich
domain like the ZFP57 binding site and preferentially acquire
H3K9me3 in the placenta. The placenta may be able to uniquely
maintain much of this monoallelic DNAmethylation throughout
development, perhaps through recruitment of protective com-
plexes. Intriguingly, unlikemice, ZFP57 is not expressed in human
oocytes but is expressed in the blastocyst (Yan et al. 2013), suggest-
ing that it may have differing roles in the protection of imprints in
human and mouse development.
Figure 6. Characteristics of placental-specific DMRs. (A) The proportion of known imprinted germline DMRs, placental-specific DMRs, and CGIs with one
or more ZFP57 binding site consensus sequences is shown. (B) Enrichment for H3K9me3, using 1000-bp sliding windows with a 1000-bp step, was com-
pared between human placenta and fetal muscle. Using the absolute difference for eachprobe, placental-specific DMRs (P = 2.2 × 10−16, t-test) andCGIs (P
= 2.2 × 10−16, t-test) showed a significant enrichment compared to all other probes, in placenta. Placental-specific DMRs were not significantly different
fromCGIs (P = 0.70, t-test). (C) Expression of genes associatedwith placental-specific DMRs based on closest transcription start site (Supplemental Table 6)
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The polymorphic imprinted methylation among the novel
DMRs in the human placenta may be explained by underlying ge-
netic variants affecting promoter usage or genomic variation af-
fecting the surrounding epigenetic profile. Alternatively, it may
be a reflection of epigenetic stochasticity present in early develop-
ment, when only a small number of cells will contribute to the de-
veloped tissue, and that such methylation states are fixed in the
placenta and not overwritten by global remethylation as occurs
in somatic lineages. The future study of genetic and genomic var-
iations in conjunction with placental methylation will help eluci-
date this.
While many genes associated with placental-specific DMRs
are expressed in placenta, the role of the monoallelic methylation
in regulating transcription remains unclear and is likely not consis-
tent across loci. Placental-specific DMRs have been shown to regu-
late monoallelic expression, includingDNMT1 (Yuen et al. 2011a;
Das et al. 2013) and the Chromosome 19 microRNA cluster
(C19MC) (Noguer-Dance et al. 2010). There are also examples of
loci where biallelic expression has been documented despite a
nearby imprinted DMR, such as at RASGRF1 and C3orf62 (Yuen
et al. 2011a). This suggests that additional factors may be impor-
tant for imprinted gene regulation, supported by the observation
in mouse that monoallelic methylation of Rasgrf1 is widespread
across tissues but onlymediates monoallelic expression in a subset
(Dockery et al. 2009). Furthermore, polymorphic imprinted ex-
pression has been described for IGF2R and SLC22A2, despite no
difference in DNA methylation (Monk et al. 2006). Therefore, it
is likely that at least some of the placental-specific imprinted
DMRs are functionally important; however, the placenta may
also present a unique epigenetic context that allows for the acqui-
sition of imprints, regardless of function. To understand this fully,
both allelic expression andmethylation will need to be interrogat-
ed across all loci in a large study population.
There are several hypotheses proposed to explain the evolu-
tion of imprinting. The most commonly discussed is the parental
conflict hypothesis (Haig and Westoby 1989; Moore and Haig
1991), which suggests imprinted genes arose through competing
interests of the maternal and paternal genetic contributions to
the developing fetus. While some of the novel DMRs identified
may fit this model, there are several aspects that do not appear
to, such as the solely maternal origin of DNAmethylation, the rel-
atively low expression of associated genes, and the lack of enrich-
ment for genes involved in growth and development (Haig 1997).
There are, however, several additional theories that may provide
insight, including the parthenogenetic protection (Solter 1988;
Hall 1990) and coadaptation (Keverne et al. 1996; Keverne and
Curley 2008) hypotheses.
The parthenogenetic protection hypothesis suggests thatma-
ternally silenced genes important for placentation and implanta-
tion would prevent progression of spurious parthenogenetic
pregnancies. This is consistent with an entirely maternal origin
of methylation and perhaps with the placental-specificity; howev-
er, imprinting of only a few genes may be sufficient for this to be
effective (Spencer and Clark 2014). The coadaptation hypothesis
suggests that there is a need to coordinate fetal development and
maternal resource management (Keverne et al. 1996; Keverne
and Curley 2008). This supports the notion that the majority of
imprinted DMRs would be maternally inherited and that, as the
site for nutrient exchange, the placenta may be enriched for im-
printed loci. Furthermore, imprinting of placental expressed genes
that may regulate maternal behavior and metabolism through se-
creted protein products, such as NPY, which regulates appetite
(Stanley et al. 1986), or RASGRF1, which has been implicated in
pancreatic function (Manyes et al. 2014), may fit this hypothesis.
Our data support that there may be multiple factors contributing
to the evolution of imprinting, particularly in the human placen-
ta, as no one theory appears to explain all aspects.
This study has shown that differentially methylated CGIs
in the oocyte can uniquely maintain imprinted DNA methy-
lation throughout pregnancy in the human placenta. The novel
placental-specific imprinted DMRs identified are not conserved
in methylation status between mouse and human and appear to
be highly polymorphic in maintenance of methylation in the
human population. Further study will be needed to understand
the underlying factors contributing to this variability in human




All placenta, fetal tissue, and blood sampleswere collected through
hospital postings with full informed consent at the BC Children’s
and Women’s Health Centre, Vancouver, BC, or anonymously
through the Embryopathology Laboratory at British Columbia
Children’s andWomen’s Hospital, Vancouver, BC. These samples
have been previously described and utilized for studies of
DNA methylation (GSE44667, GSE69502) (Yuen et al. 2011a,b;
Price et al. 2012). Collection of samples was approved by the
University of British Columbia Clinical Ethics Review Board and
the ethics committee of the Children’s and Women’s Health
Centre of British Columbia (H04-70488, H06-70085).
Control placental chorionic villous samples (N = 75) included
40 pregnancies delivered at term and 35 delivered preterm or
miscarried. The range of gestational ages was 6.0–41.6 wk and
included 37 male and 38 female conceptions. The preterm
births were associated with one or more of the following: pre-
term labor, premature rupture of membranes, chorioamnionitis,
placental abruption, and incompetent cervix. All samples were
chromosomally normal, assessed by standard karyotyping or
comparative genome hybridization, as previously described
(Robinson et al. 2010). Two to four independent sites were taken
from each placenta, from which DNA was pooled after extrac-
tion from chorionic villous. Maternal contamination was ex-
cluded using microsatellite markers (Robinson et al. 2010). To
identify imprinted DMRs in the placenta, chorionic villous sam-
ples from five diandric and five digynic triploids pregnancies
were assayed. The average (range) gestational ages for diandric
and digynic triploids were 11.2 (8–13) wk and 9.4 (8–12) wk (P =
0.18), respectively.
Thirty-two fetal tissues, including brain (N = 7), spinal cord
(N = 7), muscle (N = 9), and kidney (N = 9) were collected from
second trimester fetuses, as previously described (Price et al.
2012). Adult female whole-blood samples (N = 10) were collected
from control women. Extraembryonic cell types (N = 31), in-
cluding cord blood, cord, amniotic membrane, chorionic mem-
brane, 1st, 2nd, and 3rd trimester trophoblast and mesenchyme,
and decidua (maternal), were isolated from control placental
samples. Trophoblast and mesenchyme were enzymatically sepa-
rated from whole villi, as previously described (Henderson et al.
1996; Robinson et al. 2010); trophoblast included both cytotro-
phoblast and syncytiotrophoblast but are referred to as trophoblast
throughout. Isolated mesenchyme often contains a small propor-
tion of contaminating trophoblast cells; therefore, data frommes-
enchyme should be interpreted with caution.
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DNA methylation
Illumina HumanMethylation450 array
Using the DNeasy Blood and Tissue Kit (Qiagen), DNA was ex-
tracted and purified for all samples. For each sample, 750 ng
of DNA was bisulfite-converted using the EZ DNA Methylation
Kit (Zymo Research Corporation). DNA from five diandric
triploids, five digynic triploids, 63 control placental villi, 32 fetal
tissues, 10 adult blood, and 19 extraembryonic cell types were
run on the Infinium HumanMethylation450 BeadChip array
(Illumina). The arrays were processed as per the manufacturers’
guidelines, and data were collected on the HiScan System
(Illumina).
Using GenomeStudio software (Illumina), background inten-
sity levels were subtracted, and corrected values were exported into
R version 2.14.0 (R Development Core Team 2011). Probes that
met the following criteriawere omitted before analysis, using addi-
tional annotation (Price et al. 2013): X and Y Chromosome, detec-
tion P-value > 0.01 in at least one sample, no average B-value in
more than one sample, XY cross-hybridizing (Chen et al. 2013),
and a SNP in the target C or G. The B-values for the remaining
probes were then converted to M-values and normalized using
subset-quantile within array normalization (SWAN) (Maksimovic
et al. 2012).
Reduced representation bisulfite sequencing
DNA methylation for human oocytes (N = 5), sperm (N = 4), zy-
gotes (N = 2), two-cell embryos (N = 2), four-cell embryos (N = 2),
eight-cell embryos (N = 3), morulae (N = 3), ICM (N = 3), and
TE (N = 3) from blastocysts was obtained using publicly avail-
able low-input RRBS data (GSE49828) (Guo et al. 2014). All
bisulfite sequencing data described in this study were processed
in the same manner, unless otherwise specified: Quality was eval-
uated using FastQC Version 0.11.2, adapters and quality trimming
using Trim Galore! version 0.3.7, reads were aligned and methy-
lation calls performed in Bismark version 0.14.0 (Krueger and
Andrews 2011), and data were analyzed in SeqMonk version
0.29.0. All software can be found at http://www.bioinformatics.
babraham.ac.uk/projects/. Reads were combined from each bio-
logical replicate to represent a DNA methylation profile for each
development stage and gamete. Probes were generated using
positions from the CpG island track from UCSC (https://genome
.ucsc.edu/) with ≥5 CpGs with at least one methylation call. The
library qualitymeasures and coverage are detailed in Supplemental
Table 4.
For comparison to mouse, DNA methylation for oocytes,
sperm, ICM, TE, E6.5 epiblast, E6.5 extraembryonic ectoderm,
placenta, heart, liver, and brain was obtained from publicly avail-
able data sets (GSE51239, GSE42836, GSE34864) (Smith et al.
2012, 2014; Hon et al. 2013). For the placental data (GSE42836),
published methylation calls were utilized (Hon et al. 2013).
Orthologous regions for the known and novel placental-specific
DMRs (N = 88) were determined using the liftOver tool in UCSC
(https://genome.ucsc.edu/cgi-bin/hgLiftOver) to convert coordi-
nates from the human genome (hg19) to the mouse genome
(mm10). Of placental-specific DMRs, 88.6% had amapped orthol-
ogous region in the mouse genome, and a total of 58 loci had in-
formative methylation calls.
Multiplex bisulfite sequencing
Isolation of DNA and bisulfite conversion for 48 samples (16 pla-
cental villi, 12 trophoblast, 16 maternal blood, and four paternal
blood) were performed as described above. One hundred fifty-
one PCR assays were designed for the 43 known and 101 novel
DMRs (Supplemental Table 5). Primers were designed to contain
no SNPs or CpGs within the primer sequences and each assay to
interrogate at least one SNP. Parallel PCR reactions, with a final
concentration of 1×HotStar PCR buffer, 0.2 mM dNTPs (Life
Technologies), 1 U HotStar Taq (Qiagen), 0.4 µM each primer
pair, and 2 ng DNA, were performed in a 15-µL reaction volume
in 384-well plates. Plates were prepared on the Agilent Bravo
Workstation (Agilent Technologies). Cycling conditions included
a 15-min, 95°C denaturation, followed by 30 cycles of 95°C for 30
sec, 50°C for 30 sec, 72°C for 90 sec, with a 5-min final extension at
72°C, and reactions were performed on the C1000 Touch Thermal
Cycler (Bio-Rad).
PCR products were pooled for each sample and SPRI-purified
using Sera-Mag carboxylate-modified Magnetic SpeedBeads
(Fisher Scientific) as per the manufacturer’s recommendations.
A-overhang addition was done using 1×NEB buffer 2, 0.2 mM
dATP, 12.5 U Klenow fragment (3′->5′ exo-) (New England
Biolabs) in a 25-µL reaction incubated at 37°C for 30 min.
Following SPRI purification, Illumina adapters were ligated using
the Quick ligation kit (New England Biolabs) in a 40-µL reaction.
Following another SPRI purification, libraries were amplified
(11 cycles) and barcoded using the Sanger eight-base index in a
50-µL reaction containing: 1×High Fidelity buffer, 1 U Phusion
High Fidelity Taq (New England Biolabs), 0.2 mM dNTPs, and
0.1 µM each primer. Final libraries were SPRI-purified, and concen-
tration and quality were assessed by the 2100 Bioanalyzer system
(Agilent Technologies) and Kapa library quantification (Kapa
Biosystems). The 48 barcoded libraries were pooled and run on
the Illumina MiSeq System (Illumina) using 150-bp paired-end
reads. Allelic methylation levels and distributions were extracted
from the Bismark BAM files for reads with a linear match to the ge-
nome using a custom script (Supplemental File 1), which com-




Expression of genes associated with placental-specific DMRs in
early development was assessed using three publicly available
RNA-seq data sets (Bernstein et al. 2010; Yan et al. 2013; Metsalu
et al. 2014). Single-cell RNA-seq was utilized for TE (GSE36552),
mRNA-seq for term placenta (GSE56524), and total RNA-seq for
mid-gestation placenta (GSE18927). The single-cell RNA-seq data
were trimmed using Trim Galore! version 0.3.7 and mapped using
TopHat 2.0.12 guided by gene models from Ensembl release 61.
Quality assessment was performed using the RNA-Seq QCmodule
of SeqMonk. The mRNA-seq for term placenta was aligned using
TopHat (Trapnell et al. 2009) with Bowtie 1, and –color –quals op-
tions (since the data are in color space). Aligned BAM files for the
total RNA-seq in mid-gestation placenta were obtained directly
from Gene Expression Omnibus (GSE18927).
Gene expression as reads per kilobase per million mapped
reads (RPKM) was quantitated over exons with merged isoforms,
correcting for transcript length using the RNA-seq pipeline
quantitation in SeqMonk version 0.29.0. Placental-specific DMRs
were assessed for associated gene expression, based on the
closest TSS, using the UCSC Genome Browser gene annotation
(Supplemental Table 6). Two genes were missed due to gene anno-
tation differences between UCSC and Ensembl, the gene annota-
tion track in SeqMonk version 0.29.0, resulting in 86/88 DMRs
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Histone modifications
ChIP-seq
Publicly available ChIP-seq data for H3K9me3 in placental villi,
amniotic membrane, and fetal muscle (GSE18927) (Bernstein
et al. 2010) were assessed in SeqMonk version 0.29.0. Relative en-
richment was assessed by calculating the difference (Δ) between
placenta and somatic tissue (muscle or amnion) for each 1000-bp
probe. Values of Δ enrichment for placental-specific DMRs and
CGIswere compared to all other genome-wide probes using a t-test.
Statistical analyses
All statistical analyses were done using RStudio version 0.97.551
(RStudio Team 2015) and R version 3.0.3 (R Core Team 2014), un-
less otherwise specified.
Identifying imprinted DMRs
Using the DMRFinder tool in the CHARM package (Aryee et al.
2011), candidate DMRs were identified between diandric (N = 5)
and digynic (N = 5) triploid samples (Supplemental Table 1).
Known imprinted DMRs were those that overlapped a previously
reported human imprinted DMR with adequate coverage on the
450K array (N = 57) (Supplemental Table 2; Court et al. 2014).
Germline novel DMRs were those that were CGIs (defined by
UCSC Genome Browser [https://genome.ucsc.edu/]) that (1) were
>50% differentially methylated between sperm and oocytes, (2)
were intermediately methylated (15%–60%, based on the 90th
percentile observed at known imprinted DMRs) in the blastocyst
(average of ICM and TE), (3) showed a >5% difference in methyla-
tion between diandric and digynic triploids, and (4) showed
matching parental origin of DNA methylation between triploid
villi and gametes. Placental-specific DMRs were defined as those
with >25% and <75% DNA methylation in placenta and <25%
in somatic tissues.
Allelic DNA methylation
Reads from the RRBS data for oocyte, sperm, ICM, and TE (Guo
et al. 2014) were remapped based on phase of DNA methylation
within a given read. Reads were categorized into fully methylated,
fully unmethylated, or mixed methylation, and the proportion of
each across a given DMR was determined.
For the RRBS and multiplex bisulfite sequencing data, DNA
methylation was averaged across reads with ≥5 CpGs with a read
depth of ≥5. Reads across DMRs were binned into 10% intervals
to generate density plots of the distribution of read methylation.
For DMRs with heterozygous SNPs, percent methylation was
calculated for each allele separately for each informative individual
sample. Where possible, parental origin was assigned based on pa-
rental genotype information.
Features of placental-specific DMRs
The frequency of ZFP57 consensus motifs (TGCCGC) (Nakamura
et al. 2007; Quenneville et al. 2011) among known imprinted
DMRs, placental-specific DMRs, and CGIs was determined using
customized Perl scripts and compared using a χ2 test.
Gene ontology
The Database for Annotation, Visualization, and Integrated
Discovery (DAVID) gene ontology program was used on genes as-
sociated with placental-specific DMRs (Supplemental Table 6;
Huang da et al. 2009a,b).
Data access
Illumina Infinium HumanMethylation450 array data and multi-
plexed targeted bisulfite sequencing from this study have
been submitted to the NCBI Gene Expression Omnibus (GEO;
http://www.ncbi.nlm.nih.gov/geo/) under accession numbers
GSE74738 and GSE76273.
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